RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.
RadioPharm Theranostics has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in January 2025.
RadioPharm Theranostics's investors include Lantheus Holdings, Radium Capital.
RadioPharm Theranostics is headquartered in Carlton South, Australia.
RadioPharm Theranostics is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.
RadioPharm Theranostics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RadioPharm Theranostics — Funding & Investors." VCBacked, January 9, 2025, https://www.vcbacked.co/company/radiopharm-theranostics. Accessed August 13, 2026.
VCBacked. (2025). RadioPharm Theranostics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/radiopharm-theranostics
{{cite web |title=RadioPharm Theranostics — Funding & Investors |url=https://www.vcbacked.co/company/radiopharm-theranostics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated